Pages that link to "Q46245057"
Jump to navigation
Jump to search
The following pages link to Hepatic injury induced by bile salts: correlation between biochemical and morphological events (Q46245057):
Displaying 50 items.
- Bile acid derivatives for people with primary sclerosing cholangitis (Q24186230) (← links)
- Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production (Q28379482) (← links)
- Liver progenitor cells fold up a cell monolayer into a double-layered structure during tubular morphogenesis (Q30487320) (← links)
- Bile acid abnormalities in cholestatic liver diseases (Q33591450) (← links)
- Mechanism of hepatoprotective action of bile salts in liver disease (Q33591454) (← links)
- Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease (Q33717578) (← links)
- Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. (Q33834255) (← links)
- Mitochondrial membrane perturbations in cholestasis. (Q33836633) (← links)
- Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse. (Q33889618) (← links)
- Apoptosis and liver disease (Q33915807) (← links)
- Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. (Q33946679) (← links)
- Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium (Q34109467) (← links)
- The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent (Q34481547) (← links)
- Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease (Q34753740) (← links)
- Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats (Q35010520) (← links)
- Anti-fibrotic effect of Holothuria arenicola extract against bile duct ligation in rats. (Q35083358) (← links)
- Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin (Q35353756) (← links)
- Activation of autophagy protects against cholestasis-induced hepatic injury (Q35546306) (← links)
- Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in mice (Q35760816) (← links)
- Modulation of apoptosis as a target for liver disease (Q36066290) (← links)
- Hepatocellular apoptosis after hepatectomy in obstructive jaundice in rats (Q36180512) (← links)
- Deoxycholic acid modulates cell death signaling through changes in mitochondrial membrane properties (Q36197853) (← links)
- Yes-associated protein regulates the hepatic response after bile duct ligation (Q36200492) (← links)
- Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis (Q36389501) (← links)
- Biliary complications after liver transplantation: a review (Q36510694) (← links)
- Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets (Q36746556) (← links)
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis (Q36750284) (← links)
- microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress. (Q36890242) (← links)
- A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation (Q37383640) (← links)
- Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. (Q37418054) (← links)
- c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. (Q37643931) (← links)
- Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis (Q37890253) (← links)
- Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action (Q38058981) (← links)
- Bile acid-induced apoptosis in hepatocytes is caspase-6-dependent (Q39914977) (← links)
- Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase (Q40234761) (← links)
- Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers (Q40345193) (← links)
- Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children (Q40457634) (← links)
- Hepatoprotection by hydrophilic bile salts (Q40649152) (← links)
- Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion (Q40677743) (← links)
- Serum bile acids in companion animal medicine (Q40912170) (← links)
- The cutaneous manifestations of gastrointestinal disease (Q41185429) (← links)
- Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages (Q42254171) (← links)
- Nesfatin-1 alleviates extrahepatic cholestatic damage of liver in rats (Q42273590) (← links)
- Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture (Q42276877) (← links)
- Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat. (Q42285134) (← links)
- Differential effects between tauroursodeoxycholic and taurochenodeoxycholic acids in hepatic fibrosis: an assessment by primary cultured Ito and Kupffer cells from the rat liver (Q42554891) (← links)
- Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. (Q42840910) (← links)
- Beneficial effect of caffeic acid phenethyl ester (CAPE) on hepatocyte damage induced by bile duct ligation: an electron microscopic examination (Q43009583) (← links)
- Darbepoetin-α inhibits the perpetuation of necro-inflammation and delays the progression of cholestatic fibrosis in mice. (Q43010284) (← links)
- Lipid and protein oxidation in hepatic homogenates and cell membranes exposed to bile acids. (Q43294354) (← links)